From Insight to Impact: Certainty EMEA 2025
See how GenAI, unified digital trials, and a Totality of Evidence approach transform regulatory docs,…
Certara2025 年 11 月 17 日
ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™
At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…
Certara2025 年 11 月 13 日
Certara Reports Third Quarter 2025 Financial Results
RADNOR, PA— 2025 年 11 月 6 日-- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug development,…
Certara2025 年 11 月 6 日
Certara Expands Biosimulation Market with AI-Driven QSP Platform
Discover how Certara IQ accelerates drug development through scalable, QSP Modeling with AI-Powered Biosimulation.
Certara2025 年 10 月 30 日
At Certara, we’re proud to support WBUR, Boston’s NPR.
Certara supports public radio because NPR is aligned with our values and helps us spread…
Certara2025 年 10 月 29 日
Best Practices for AI Prompt Engineering in Life Sciences in 2025
AI prompt engineering is an essential skill for using LLMs. Read our blog for best…
Certara2025 年 10 月 23 日
Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results
Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…
Certara2025 年 10 月 15 日
Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science
Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…
Certara2025 年 9 月 22 日
Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC
Join Certara's Fall 2025 Certainty Circuit in EMEA & APAC to explore AI-enabled biosimulation insights,…
Certara2025 年 9 月 17 日
